Overview
- 20 FDA inspections are on record.
- 10 inspections produced a Form 483.
- The most recent recorded inspection date is 2022-05-17.
At a glance
Inspections
20
Form 483s
10
EIRs
3
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 18 Apr 2022 – 17 May 2022 | Human Drugs | 483 | View 483 → |
| 23 Jul 2018 – 30 Aug 2018 | Human Drugs | 483 | View 483 → |
| 2 May 2017 – 12 May 2017 | Human Drugs | Clean | |
| 22 Feb 2016 – 4 Apr 2016 | Human Drugs | 483 | On file |
| 19 May 2015 – 5 Jun 2015 | Human Drugs | 483 | On file |
| 7 Apr 2014 – 29 May 2014 | Human Drugs | 483 | On file |
| 1 Feb 2013 | Not recorded | 483 | On file |
| 11 May 2012 | Not recorded | 483 | On file |
| 19 May 2011 | Not recorded | 483 | View 483 → |
| 6 Oct 2009 | Not recorded | Clean | |
| 12 Jun 2009 | Not recorded | Clean | |
| 10 Oct 2008 | Not recorded | Clean | |
Observations on record
Form 483 observations cited at this site, most recent first.
Procedures for sterile drug products
Cited by Guerlain Ulysse, Mindy M Chou, Ko U Min, Nicholas A Violand, Natasha Gupta
Following/documenting laboratory controls
Cited by Guerlain Ulysse, Mindy M Chou, Ko U Min, Nicholas A Violand, Natasha Gupta
Scientifically sound laboratory controls
Cited by Guerlain Ulysse, Mindy M Chou, Ko U Min, Nicholas A Violand, Natasha Gupta
Written program not followed
Cited by Guerlain Ulysse, Mindy M Chou, Ko U Min, Nicholas A Violand, Natasha Gupta
Written procedures followed
Cited by Guerlain Ulysse, Mindy M Chou, Ko U Min, Nicholas A Violand, Natasha Gupta
Investigators
FDA investigators tied to this site in the record.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 10x |
| 21 CFR 211.22(a) | Cited across public-safe Form 483 observations | 6x |
| 21 CFR 211.113(b) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.166(a) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.68(b) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.160(b)(3) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.160(b)(4) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.194(a)(8) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.67(b)(3) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.160(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.165(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.186(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(10) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 314.81(b)(1)(ii) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Akorn Inc.'s 10 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat